Welcome to our dedicated page for Ultralife Corporation news (Ticker: ULBI), a resource for investors and traders seeking the latest updates and insights on Ultralife Corporation stock.
Ultralife Corporation (symbol: ULBI) is a global company that started as a battery manufacturer and has since diversified its offerings to include a wide range of portable and standby power solutions, as well as communications and electronics systems. Established in 1990 and publicly traded since 1992, Ultralife operates through two main segments: Battery and Energy Products and Communications Systems.
The Battery and Energy Products segment is the primary revenue generator and offers a comprehensive range of rechargeable and non-rechargeable batteries, chargers, and accessories. These products serve various markets, including commercial, medical, and military sectors. The product lineup includes lithium 9-volt batteries, cylindrical batteries, and other non-rechargeable battery types.
In the Communications Systems segment, Ultralife provides power and amplification solutions that complement numerous commercial and military portable radios and communication systems. This suite of products is critical for ensuring reliable performance in demanding environments.
Ultralife’s family of brands includes Ultralife Batteries, Able, McDowell Research, AMTI, and Accutronics Ltd, with operational footprints spanning North America, Europe, and Asia. This extensive brand portfolio and global presence enable Ultralife to reach diverse markets and meet various customer needs.
Recent achievements include the expansion of their LinkedIn showcase pages dedicated to their battery & energy solutions and communication systems. These platforms provide the latest updates and developments, ensuring stakeholders stay informed about new products, financial performance, and other significant company news.
Ultralife Corporation continues to innovate and adapt to the changing demands of its diverse customer base. By focusing on quality, reliability, and innovation, the company maintains its reputation as a trusted provider of power and communication solutions globally.
Ultralife Corporation (NASDAQ: ULBI) reported a third quarter operating loss of $0.8 million on revenues of $21.8 million, a 10.7% decline compared to $24.4 million in Q3 2020. The decrease was largely due to supply chain bottlenecks affecting both the company's and customers' manufacturing schedules, with a notable 39.7% drop in government/defense sector sales. Despite these challenges, commercial sales rose 5%, and backlog increased 22% over the previous quarter. The company maintained a strong cash position of $15.9 million.
Ultralife Corporation (NASDAQ: ULBI) has secured a purchase order worth approximately $4.2 million to deliver Vehicle Amplifier-Adaptors (VAA) for the U.S. Army’s Leader Radio program, developed by Thales Defense & Security. Shipments are set to begin in 2022. The Leader Radio, following successful operational tests, enhances soldiers' communication capabilities by integrating voice and data functionalities into one system. Ultralife's President, Michael D. Popielec, expressed satisfaction with this follow-on order, highlighting its alignment with their strategic development approach.
Ultralife Corporation (NASDAQ: ULBI) will announce its third quarter financial results for the period ending September 30, 2021, prior to market opening on Thursday, October 28, 2021. The company will hold an investor conference call and webcast at 8:30 AM ET on the same day. To participate, dial (800) 915-4836. A replay of the call will be available shortly after. Ultralife, headquartered in Newark, New York, offers a range of products in power solutions and communications, serving government and commercial clients globally.
Ultralife Corporation (NASDAQ: ULBI) reported a second-quarter operating income of $1.1 million on $26.8 million in revenue, down from $28.6 million in Q2 2020. Despite a 3% sequential sales increase from Q1, year-over-year revenue decreased by 6.3%. Notably, oil & gas revenues surged by 49% year-over-year, while sales from government/defense dropped by 13.2%. Delayed shipments due to supply chain issues impacted revenue by approximately $1.5 million. Cash position improved by 15.9% to $15.8 million, while debt decreased by 36.6% to $0.7 million.
Ultralife Corporation (NASDAQ: ULBI) will announce its second quarter results for the period ending June 30, 2021, before market opening on July 29, 2021. Management will conduct a conference call at 8:30 AM ET on the same day. Investors can join by calling (800) 915-4836 or via a live webcast available on the company’s investor relations page. A replay of the webcast will be accessible shortly after the live event. Ultralife specializes in power solutions and communication systems, serving various global markets including government and defense.
Ultralife Corporation (NASDAQ: ULBI) has secured a firm-fixed price contract from the U.S. Army for Conformal Wearable Batteries, valued at up to $168 million over three years. The contract may extend to an additional $350 million based on one-year options. This award is part of a $1.25 billion program aimed at enhancing soldier mobility with lightweight batteries that sustain operations for up to 24 hours. Ultralife's selection underscores its reputation for reliability and safety in military applications.
Ultralife Corporation (NASDAQ: ULBI) reported a slight increase in revenue to $26.0 million for Q1 2021, up 0.6% year-over-year. Operating income fell to $1.0 million, down from $1.5 million in the same quarter last year. The company saw a 32% increase in medical device battery sales and 30% growth in government/defense sales, but these were offset by a 30% decline in oil & gas market sales and a 23.6% decrease in Communications Systems sales. Net income was $0.7 million or $0.04 per diluted share, reflecting $2.0 million adverse impact from COVID-19.
Ultralife Corporation (NASDAQ: ULBI) is set to announce its first quarter results for the period ending March 31, 2021, before the market opens on April 29, 2021. The management will follow with an investor conference call at 8:30 AM ET the same day. Interested participants can join the call by dialing (800) 915-4836. A live webcast will also be available on the company's website, with a replay accessible shortly after the call. Ultralife offers a range of products and services in power solutions and communication systems globally.
Ultralife Corporation (NASDAQ: ULBI) reported mixed Q4 2020 results with revenue of $29.0 million, down 6.6% from $31.0 million in Q4 2019. GAAP EPS increased to $0.13 from $0.10, while Adjusted EPS rose to $0.17 from $0.13. Operating income dropped to $1.2 million from $2.5 million amid a $2.6 million negative impact from COVID-19. Medical battery sales surged 94%, but oil & gas market sales fell 67.4%. The company's debt was reduced by 91.5% to $1.5 million, and cash-on-hand grew 43.9% to $10.7 million, highlighting resilience amidst challenges.
FAQ
What is the current stock price of Ultralife Corporation (ULBI)?
What is the market cap of Ultralife Corporation (ULBI)?
What does Ultralife Corporation do?
When was Ultralife Corporation founded?
What are the main segments of Ultralife Corporation?
What products are offered by the Battery and Energy Products segment?
Where does Ultralife Corporation operate?
Which brands are part of Ultralife Corporation?
How does Ultralife Corporation keep stakeholders informed?
Who are the primary customers of Ultralife Corporation?
What recent achievements has Ultralife Corporation made?
How does Ultralife Corporation ensure product reliability?
